In my previous post, I described the complex challenges NGS Clinical Diagnostic laboratories face because of legacy software. To recap, these include limitations in usability and efficiency, higher costs than labs generally understand, the difficulties that arise when you need to replace key personnel, and the lack of specialized software expertise in internal development teams. For laboratory and technical leads […]
Read More
Laboratory and technical leads face a number of complex challenges when changes to an existing process are required. Whether they want to add new assays, tests or products, take advantage of new equipment, or scale throughput, these challenges can lead them to wonder: Are my legacy systems adequate? Can or should these legacy systems be further customized? Should we consider […]
Read More
Next-generation sequencing (NGS) clinical diagnostic labs are playing a key role in efforts to assess the spread of the COVID-19 virus and to develop a vaccine and therapeutics. At the same time, they continue to collaborate and innovate, develop breakthroughs, and advance patient outcomes. In this post, we look at a few standout examples. Exciting Partnerships & Collaborations Driving Change […]
Read More